Subcutaneous and epicardial adipose tissue mRNA expression of CD14, CD45, CD68.
INTRODUCTION
Increased incidence of obesity and type 2 diabetes worldwide stimulated intensive research focusing on the detailed etiopatogenesis of its relationship. During the last decade a lot of new knowledge have been gained in this field including the discovery of endocrine function of adipose tissue (1; 2). It is now generally accepted that adipose tissue secretes numerous hormones and cytokines that can have both insulin resistance-inducing and insulin-sensitizing effects (3; 4) . Endocrine dysfunction of adipose tissue together with an excessive ectopic lipid storage in non-adipose tissues such as liver and muscle is now considered the major player in the etiopatogenesis of obesity-related insulin resistance (5; 6).
Increased blood glucose levels and decreased sensitivity to insulin effects frequently occur also in critically ill patients even without previous history of diabetes mellitus (7) . Numerous studies have documented that increased blood glucose levels worsen morbidity and mortality in critically ill patients (8; 9) and that intensive insulin therapy aimed at maintaining euglycemia markedly improves the outcome of these patients (10; 11).
The etiopatogenesis of insulin resistance in critically ill patients is still only partially understood and likely includes both some of the mechanisms analogical or similar to that of obesity-induced insulin resistance and other processes. Major patophysiological conditions underlying hyperglycemia in critical illness include enhanced hepatic gluconeogenesis, impaired insulin secretion and decreased insulin sensitivity due to anti-insulin effects of stress hormones and proinflammatory cytokines (7; 9; 12) . The exact mechanisms at the molecular level still remain to be elucidated.
While the involvement of adipose tissue hormones in the obesity-induced insulin resistance has been studied extensively (3; 4) there is scarce information about its changes in critically ill patients.
Recently, epicardial adipose tissue has been identified as a source of several proinflammatory cytokines and have been implicated as a possible player in the development of coronary artery disease (13; 14) . Here we studied the dynamic changes of several proinflammatory and anti-inflammatory adipose tissue-derived hormones both on systemic and local level as measured by changes of its mRNA expression in subcutaneous and epicardial adipose tissue. We demonstrate that both epicardial and subcutaneous adipose tissue becomes a significant source of proinflammatory factors after major elective cardiac surgery operation and thus may contribute to the development of insulin resistance in these patients. 
MATERIAL AND METHODS

Anthropometric examination and sampling
Anthropometric examination of the patients was performed at basal state one day before operation. All subjects were measured and weighted and BMI was calculated.
Blood samples for hormonal measurement were taken at basal state (before the start of anesthesia), at the end of operation and 6, 12, 24, 48 and 120 hours after the end of operation, respectively. Serum was obtained by centrifugation and the samples were subsequently stored in aliquots at -70 °C until further analysis.
Samples of the subcutaneous and epicardial adipose tissue for mRNA expression analysis were taken at the beginning and before the end of surgery. Subcutaneous samples were from the thoracic region. All of the samples (both at the beginning and at the end of operation)
were taken from approximately same location in all of the patients. The samples were obtained from the tissue that has not been previously traumatized mechanically or by cauterization to avoid the influence of local damage on tissue parameters. Tissue samples were collected to RNAlater reagent (Qiagen, Germany) and stored at -70 °C until further analysis. The average time between the withdrawal of the sample at the beginning and at the end of operation was 252±27 minutes.
Blood glucose was monitored in hourly intervals during first 48 hours of stay on ICU and in 1-4 hours intervals based on the actual glucose levels afterwards. Insulin infusion was started at the time of admission to ICU (within 5 minutes after the end of operation). Insulin infusion rate was adjusted according to internal glucose control protocol aiming to maintain blood glucose within euglycemic limits (4.4-6.1 mmol/l).
Hormonal and biochemical assays
Blood glucose was measured on ABL 700 analyzer (Radiometer Medical A/S, Copenhagen, Denmark). Serum concentrations of insulin, interleukin-6, TNF-α, leptin and MCP-1 were measured using Human serum adipokine LINCOplex Kit (panel B) on Luminex®200 instrument (Linco Research, USA) . Sensitivity was 1.6 pg/ml for IL-6, 85.4 pg/ml for Leptin, 0.14 pg/ml for TNF-alpha, 0.14 pg/ml for MCP-1 and 50.9 pg/ml for Insulin. Intra-and interassay variability of kit were 1.4-7.9% and <21%, respectively.
Serum adiponectin concentrations were measured by commercial RIA kit (Linco Research, St. Charles, Missouri, USA). Sensitivity was 1.0 ng/ml, and the intra-and interassay variability were 1.8% and 9.3%, respectively. Serum resistin concentrations were measured by commercial ELISA kit (BioVendor, Czech Republic). Sensitivity was 0.2 ng/ml, and the intra-and interassay variability were 3.1% and 6.5%, respectively. Serum cortisol concentrations were measured using Cortisol RIA kit (Immunotech, Czech Republic)
Sensitivity was 10 nmol/l, and the intra-and interassay variability was 5.8% and 9.2%, respectively.
Determination of mRNA expression:
Approximately 100mg of tissue was collected to 1ml of RNA stabilization Reagent To compensate for variations in input RNA amounts and efficiency of reverse transcription, beta-2-microglobulin was used as an endogenous reference and results were normalized to these values. Relative gene expression of genes was calculated using the formula 2
.
Statistical analysis
The statistical analysis was performed on SigmaStat software (Jandel Scientific, USA). The results are expressed as means ± standard error means (SEM). Changes of hormonal levels and gene expression during perioperative and postoperative state, respectively, were evaluated using RM ANOVA or paired t-test as appropriate.
RESULTS
Blood glucose levels and insulin requirements
Mean blood glucose level during the first 48 hours of stay on ICU was 6.5±0.13 mmol/l, mean 48-hours insulin consumption was 204±37.6 IU ( Table 1) . Average insulin infusion rate was 4.01± 0.77 IU/h (Table 1) . Glucose concentrations, insulin infusion rate and serum insulin levels during first 48 hours of ICU stay are shown in Figure 1 .
Serum hormonal and cytokine concentrations
Serum concentrations of insulin, resistin, interleukin-6, MCP-1, TNF-α, adiponectin, leptin and cortisol at basal state and during postoperative period up to 120 hours after operation are shown in Figure 1 and Figure 2 , respectively. All of the serum hormonal concentrations with the exception of adiponectin were significantly affected by the operation. The time pattern of changes of insulin and interleukin-6 was very similar. Both insulin and interleukin-6 levels increased moderately after the operation, peaked 6 and 12 hours after operation, respectively and remained 2-3 times elevated even 120 hours after operation (Figure 1 and 2) . Serum TNF-α showed a two-peak pattern: with increments at 6 and 20 hours after the end of operation ( Figure 2 ). Leptin levels doubled 6 hours after the end of operation, peaked 12 and 24 hour after operation, respectively and normalized until 120 hour after operation ( Figure 2 ). MCP-1 levels peaked at the end of operation (3-fold increase over the baseline) and returned to basal levels 48 hours after the operation (Figure 2 ). Resistin levels showed the slowest pattern of increase with peaks 24 and 48 hours after operation, respectively, remaining still 2-fold elevated 120 hours after the end of operation (Figure 2 ). In contrast, serum adiponectin concentrations only tended to decrease during the operation and returned to preoperative levels 120 hours after the end of operation (Figure 2) . None of the changes of adiponectin levels reached the statistical significance. Serum cortisol levels increased after the end of operation, peaked 12 hours after the end of operation and normalized 120 hours after the end of operation (Figure 2 ).
Changes of mRNA expression of selected adipose tissue-derived hormones and cytokines
At baseline, TNF-α mRNA expression was significantly higher in epicardial relative to subcutaneous adipose tissue, while no significant differences between the two adipose tissue depots were found for leptin, adiponectin, resistin, MCP-1 and interleukin-6 expression 
DISCUSSION
The most important finding of this study is that both epicardial and subcutaneous adipose tissue can produce significant amounts of proinflammatory factors after activation of immune system and stress axis by major cardiac surgery operation. Epicardial adipose tissue as a source of inflammatory mediators under basal conditions has been identified previously (13; While the possible involvement of epicardial adipose tissue in the production of interleukin-6, TNF-α and MCP-1 has been described previously (13; 20) , its role in the production of resistin has not been extensively studied by far. In the only report available, Baker et al. found resistin expression in epicardial adipose tissue comparable to that in abdominal subcutaneous and visceral adipose tissue and higher than in gluteal subcutaneous adipose tissue (14) . Here we did not see significant differences in resistin mRNA expression between epicardial and subcutaneous adipose tissue from the thoracic region and found a postoperational increase in its expression in both subcutaneous and epicardial adipose tissue.
Resistin was originally discovered as an adipocyte-derived hormone increased in obesity and was suggested to link obesity to insulin resistance (21) . Further studies revealed that its major role in humans may lie rather in its proinflammatory than insulin resistance-inducing action and that in humans it is produced rather by activated immunocompetent cells than adipocytes (22) (23) (24) (25) . Here we show for the first time that resistin behaves similarly to other In addition to proinflammatory mediators, adipose tissue also produces adiponectin -a protein hormone with significant insulin-sensitizing, anti-inflammatory and anti-atherosclerotic properties (4; 26; 27) . In contrast to proinflammatory factors such as resistin, interleukin-6, TNF-α and MCP-1 markedly affected by the cardiac surgery operation no significant changes were detected in serum adiponectin levels or its adipose tissue mRNA expression. This suggests that in contrast to resistin, interleukin-6, TNF-α and MCP-1 the changes in circulating adiponectin levels are probably not involved in the etiopatogenesis of insulin resistance in critically ill patients. However, it has to be noted that by measuring total adiponectin levels we may have missed the changes of its circulating fractions that can also modulate insulin sensitivity as was demonstrated previously (28) .
Despite an attractive hypothesis of significant role of adipose tissue-derived factors as important players in the insulin resistance of critically ill patients it is important to interpret our findings cautiously. Firstly, mRNA expression of adipose tissue-derived factors was measured only in subcutaneous adipose tissue in thoracic region and epicardial adipose tissue in our study and it is unknown if such changes also appear in other fat deposits. Secondly, circulating monocytes and macrophages activated by the operation can also significantly contribute to the circulating pool of proinflammatory cytokines. It is also important to note that many other factors in addition to proinflammatory cytokines such as cortisol, catecholamines, growth hormone and other stress-related factors can significantly contribute to the development of insulin resistance in critically ill patients (29) . For example: cortisol has been found to induce insulin resistance in both muscle (30) and liver (31) and its decrease by adrenalectomy under experimental conditions markedly decreased hyperglycemia and improved insulin sensitivity in different rodent models of insulin resistance (32; 33).
Conversely, increased cortisol levels in patients with endogenous hypercortisolism such as Cushing syndrome induce insulin resistance which disappears after normalization of cortisol levels by appropriate treatment (33; 34). Cortisol levels were significantly elevated in the postoperative period in our study and therefore very likely contributed to the development of insulin resistance together with other stress-induced hormones (29) .
In summary, we have demonstrated that both subcutaneous and epicardial adipose tissue becomes an important source of proinflammatory factors in patients with major cardiac surgery operation. These factors together with other hormonal and metabolic changes contribute to the development of insulin resistance in these patients. Our finding suggests that therapeutic approaches suppressing proinflammatory factors production in adipose tissue may represent a new modality of prevention and/or treatment of insulin resistance in critically ill patients.
Figure Legends
Figure 1
Blood glucose levels, insulin infusion rate and serum insulin levels in cardiac surgery patients.
Samples for insulin measurements were taken at baseline (before the start of anesthesia, 
